Video Experimental Relacionado
Updated: May 15, 2026
11:36
In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
La inactivación del efector de apoptosis Apaf-1 en el melanoma maligno
M S Soengas1, P Capodieci, D Polsky
1Cold Spring Harbor Laboratory, New York 11724, USA.
Nature
|February 24, 2001
Resumen
Los melanomas metastásicos a menudo inactivan Apaf-1, una proteína clave para la muerte celular programada. La restauración de los niveles de Apaf-1 puede volver a sensibilizar las células de melanoma quimiorresistentes al tratamiento.
Área de la Ciencia:
- Oncología Oncología.
- Biología Molecular Biología Molecular
- Investigación de Investigación del Cáncer.
Sus antecedentes:
- El melanoma metastásico es un cáncer quimiorresistente con una pobre comprensión molecular.
- Las mutaciones de p53 son comunes en los cánceres quimiorresistentes, pero son raras en el melanoma.
- Apaf-1, un efector de la muerte celular, media la apoptosis dependiente de p53.
Objetivo del estudio:
- Para investigar el papel de Apaf-1 en el melanoma metastásico.
- Comprender los mecanismos moleculares que subyacen a la quimiorresistencia en el melanoma.
Principales métodos:
- Análisis de la expresión de Apaf-1 en melanomas metastásicos.
- Investigación de la pérdida y metilación alélica de Apaf-1.
- Tratamiento de las líneas celulares del melanoma con 5-aza-2'-deoxicitidina (5aza2dC).
- Transferencia de genes para restaurar los niveles de Apaf-1.
Principales resultados:
- Los melanomas metastásicos con frecuencia pierden la expresión de Apaf-1, asociada con la pérdida de alelos.
- La pérdida de Apaf-1 puede revertirse mediante la inhibición de la metilación (5aza2dC).
- Los melanomas apaf-1-negativos muestran quimiorresistencia y apoptosis defectuosa.
- La restauración de Apaf-1 mejora la quimiosensibilidad y rescata los defectos apoptóticos.
Conclusiones:
- La inactivación de Apaf-1 es un evento clave en el desarrollo del melanoma metastásico.
- La pérdida de Apaf-1 contribuye a la quimiorresistencia y la apoptosis defectuosa en el melanoma.
- La inactivación de Apaf-1 puede explicar la baja frecuencia de las mutaciones p53 en el melanoma.
Más Videos Relacionados
Videos de Conceptos Relacionados
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:24Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...